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A set of plasmids containing portions of the Co1 E 1 plasmid were transformed into recA- cells. These cells, 
after UV irradiation, only incorporate labelled amino acids into plasmid-encoded proteins. UV-irradiated 
cells label a 14.5 kDa band if they are phenotypically immune to colicin El, and do not contain this band 
if they are sensitive to colicin El. We conclude that the 14.5 kDa protein is the colicin E I immunity protein. 
When the inner and outer membranes of these cells are fractionated, the labelled band appears in the inner 
membrane. The immunity protein must be an intrinsic inner membrane protein, confirming the predictions 
made by hydrophobicity calculations from primary sequence data. 
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1. INTRODUCTION 
The Co1 plasmids are a class of Escherichia coli 
plasmids that instruct the synthesis of proteins 
called colicins that are lethal to bacteria of the 
same or similar groups. Each Co1 plasmid must 
also code for a corresponding protein that protects 
the cell from the killing action of the colicin. This 
additional protein is said to confer colicin 
immunity. 
The mechanisms of many colicin immunities are 
not yet elucidated, but it is known that the interac- 
tions are always highly specific. For example, the 
El class of colicins (Ia, Ib, El, A, and K) all seem 
to kill sensitive cells in the same manner: dissipa- 
tion of transmembrane potential by formation of 
a rather non-specific channel in the inner mem- 
brane [ 11. There is no cross-reactivity between dif- 
ferent colicins and their immunity proteins. Co- 
licins Ia and Ib share the same outer membrane 
receptor, the same killing mechanism and even 
some partial sequence homology, yet their respec- 
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tive immunity proteins are specific for only one of 
the 2 molecules [2]. Immunity for E 1, A and K co- 
licins is also specific. 
The work of Weaver et al. [2] on the colicin Ia 
system has allowed them to identify the colicin Ia 
immunity protein as a polypeptide of approx. 
14.5 kDa residing as a component of the inner 
membrane of E. coli. This is a plausible result since 
it must interact with the colicin Ia protein whose 
target is the inner membrane. 
Previous attempts at identifying the size and 
location of the colicin El immunity protein have 
proved inconclusive. Polypeptides ranging from 
6.5 to 14.3 kDa have been tentatively identified as 
the immunity protein using such techniques as 
minicells and in vitro synthesis [3-51. 
We have taken advantage of 2 results in our 
search for the colicin El immunity protein. The 
first is the availability of the elegant maxicell 
technique of Sancar et al. [6] which allows one to 
label exclusively plasmid-encoded proteins. The 
second is the availability of some well-character- 
ized plasmids containing portions of the Co1 El 
plasmid that confer a variety of phenotypes. 
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Furthermore, the availability of nucleatide se- 
quence data for the plasmids we use offers us addi- 
tional predictive capability. By reading a proposed 
amino acid sequence from the gene sequence, we 
can use hydrophobicity calculations [7] to garner 
information on the possible cellular locations of 
these plasmid proteins. Using these tools we have 
positively identified the colicin El immunity pro- 
tein and determined its cellular location in the E. 
coli inner membrane. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains and plasmids 
A-21 [sup A recA-21 (thr- leu- mall sor- 
recA_)] is a derivative of E. coli K-12 via AB1157 
from G. Walker. The plasmid entitled p8 is 
pDMS630 from J. Inselburg and is a derivative of 
the Co1 El plasmid containing a Tn3 transposon 
that confers ampicillin resistance. p8 is col+ imm+ 
ampR. ~215 is pHSG215 also from J. Inselburg 
and is col- imm+ tetR. 
p4 was obtained from ~215 by in vitro 
mutagenesis with 1 M hydroxylamine (pH 6.0), 
0.6 M NaCI. Samples were removed at 45-min in- 
tervals and quenched with 0.7 M Tris-HCl (pH 
8.0), 0.8 M NaCl. DNA was precipitated and 
resuspended in TEC buffer. p4 is col- imm- tetR, 
and was selected from transformants on 
tetracycline and colicin-containing LB plates. 
2.2. Materials 
[35S]Methionine (> 1200 Ci/mmol) was pur- 
chased from Amersham. Antibiotics, D- 
cycloserine and lysozyme were purchased from 
Sigma. Enhance@was purchased from New Eng- 
land Nuclear. 
2.3. Methods 
Maxicells were prepared by the modified pro- 
cedure of Sancar et al. [6]. 
The separation of inner and outer membranes 
basically followed the procedure of Ito et al. [8]. 
All procedures were done at 0-4°C. Membranes 
were resuspended in Tris buffer and homogenized 
for electrophoresis. The purity of inner and outer 
membrane fractions was checked using marker en- 
zyme assays as described in Ito et al. [8]. 
Polyacrylamide gel electrophoresis was per- 
formed in the presence of SDS using the discon- 
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tinuous buffer system of Laemmli [9]. For auto- 
radiography, gels were treated for 1 h with 
Enhance followed by 1 h in 10% acetic acid/2% 
glycerol, then dried under vacuum with heating 
and exposed 2-3 days to Kodak X-ray film at 
- 7ooc. 
3. RESULTS AND DISCUSSION 
Using the maxicell technique, we can successful- 
ly label plasmid proteins with [3’S]methionine and 
leave chromosomal proteins unlabelled. A-21 max- 
icells that contain no plasmid incorporate no label 
into protein (not shown). 
p4 is a hydroxylamine-mutagenized derivative of 
~215 that is phenotypically non-immune (i.e. 
colicin-sensitive). Cells containing either p4 or 
~215 are tetracycline-resistant. A 37 kDa protein 
has been previously identified in pBR322- 
containing maxicells as the tetracycline-resistance 
protein [6] and that band is clearly seen in both p4 
and ~215 maxicells. There are a few other faint 
bands in both strains, but the significant difference 
is the presence of a major band in ~215 cells at ap- 
prox. 14.5 kDa that is totally absent in p4 cells. 
This band, which is also present in p8 cells, must 
correspond to the immunity protein. 
Maxicells containing p8 appear to incorporate 
label into a large array of proteins, far greater than 
could be coded for on the 11.6 kilobases of the p8 
plasmid. Using rabbit anti-colicin El antibodies we 
have found that colicin-producing cells contain 
proteins with colicin El antigenic determinants 
over a range of molecular masses up to about 
60 kDa (not shown). We interpret this as a set of 
degradation products and proteolytic fragments of 
the colicin molecule that are naturally occurring in 
colicin producers. Thus maxicells containing p8 
should label a whole variety of colicin fragments, 
and this is the observed result. 
Additionally, p8 maxicells must express labelled 
ampicillin resistance gene products which are 
characteristically seen in the 28-31 kDa range. p8 
cells are also phenotypically immune, and so must 
contain the labelled immunity protein. 
Inner and outer membranes were isolated from 
[35S]methionine-labelled maxicells as outlined in 
section 2. Protein content was determined by the 
method of Lowry et al. [lo] and equal amounts of 
protein of inner and outer membranes of p4, p8 
Volume 190, number 2 FEBS LETTERS October 1985 
B 
tet - 
amp- 
imm 
46 
f8 
Fig. 1. [35S]Methionine incorporation into plasmid- 
coded proteins in maxicells. Maxicells were UV- 
irradiated, then labelled with 13?3)methionine. Cells were 
subjected to SDS-PAGE followed by autoradio~raphy 
as described in text. Lanes: (a) A-21 maxicells containing 
p4, (b) A-21 (p8), (c) A-21 (~215). 
and ~215 cells were subjected to SDS-PAGE. The 
results are seen in fig.2. 
In p4 and ~215 cells we see strong bands cor- 
responding to tetracycline-resistance protein, a 
known inner membrane protein. The enriched 
tat -
ikd) 
Fig.2. (A) Labelied polypeptides in maxiceil inner 
membranes. (B) Labelled polypeptides in maxicell outer 
membranes. Inner and outer membrane extracts of 
[%]methionine-labelled maxicells were prepared as 
described in text and subjected to SDS-PAGE followed 
by autoradiography. Lanes are A-21 containing: (a) p4, 
(b) ~8, 6) ~215. 
amount of the 14.5 kDa band in the inner mem- 
brane fraction supplies the best evidence so far that 
the immunity protein resides in the inner 
membrane. 
In p8 we see a great reduction in the number of 
colicin fragments, although some intact colicin is 
still present. The ampicillin resistance proteins (in- 
cluding ~-lactamase) are cytosohc and do not ap- 
pear in membrane fractions. 
Not surprisingly, very Iittle label ends up in the 
outer membrane fraction. In p8, coficin (mostly in- 
tact) does show up in the outer membrane. The 
outer membrane contains the known receptor for 
the colicin El molecule 1111, thus we expect to find 
some intact coiicin associated with the outer 
membrane. 
We have positively identified an inner mem- 
brane protein that‘ occurs only in cells that are 
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phenotypically immune to colicin El, and not in 
sensitive cells. We believe that this 14.5 kDa pro- 
tein is the colicin El immunity protein. 9 
The nucleotide sequence for the plasmids used 
October 1985 
here is available from pBR322 or pCo1 El data :: 
[ 12-141, and the amino acid sequence for the col- 
icin El protein has been determined. It is known 
g 
2 
that almost all of the molecule is highly S: 
hydrophilic and there is a short region near the car- T 
boxy terminus that is hydrophobic which is includ- 
ed in the channel portion of the molecule (fig.3a). 
Thus we might expect to find endogenous colicin 
El in the cytosol and in the membrane fraction of Z 
maxicells. 
The phenomenon of colicin degradation is not 
uncommon. The process of colicin killing itself 
may indeed involve the clipping of the 20 kDa 
carboxy-terminal fragment for insertion into the 
membrane. The action of internal bacterial pro- 
teases may be necessary for cell survival. In vitro 
experiments how that trypsin, chymotrypsin and 
other proteases degrade colicin leaving a 20 kDa 
fragment intact [ 15-181. A 17 kDa band that may 
correspond to this colicin fragment is prevalent in 
p8 maxicells, both in whole cells and in inner mem- 
brane fractions (see figs 1 and 2). We are currently 
testing this possibility by using monoclonal an- 
tibodies against specific domains of the colicin El 
molecule [ 191. 
The sequence which must correspond to the 
37 kDa tetracycline-resistance protein codes for a 
protein whose hydrophobicity profile is that of a 
membrane protein (fig.3b). It contains long 
hydrophobic regions (membrane-spanning) with 
shorter interspersed regions of relative hy- 
drophilicity. A similar look at the putative se- 
quence for the colicin El immunity protein shows 
that it looks much like a membrane protein 
(fig.3c). This 113-amino-acid transcript is the only 
reasonably lengthened coding region in the known 
Fig.3. Hydrophobicity plots for 3 proteins from pCol El 
and pBR322, according to the method of Kyte and 
Doolittle [7]. Hydrophobicity values for individual 
amino acids are consensus values from Eisenberg [21] 
and are averaged over the stated number of residues. (a) 
Colicin El protein, (b) tetracycline resistance protein, (c) 
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area of immunity on the Co1 EI plasmid and in the 
proper direction of transcription [20]. Its proposed 
molecular mass corresponds well to the value we 
report. Furthermore, a DNA fragment containing 
this coding region has been isolated and cloned in- 
to two new vectors to create new, immunity- 
conferring plasmids (Shanafelt, A., Goldman, K., 
Kastelein, R. and Kayalar, C., submitted). 
Although the immunity protein is easily visual- 
ized by the maxicell technique, both Coomassie 
blue and silver staining of SDS gels fail to detect 
any extra bands in cells containing immunity- 
conferring plasmids (not shown). This indicates 
that the immunity protein is in relatively low abun- 
dance, and yet it is able to protect cells against 
large amounts of external colicin. This may imply 
a catalytic mode of action for the immunity pro- 
tein, however, it is not known how much of the ex- 
ternal colicin reaches the inner membrane. It has 
been hypothesized that very little actually does. 
Since the immunity protein has to act only against 
the colicin reaching the inner membrane, its action 
may still be stoichiometric. Experiments in finding 
temperature-sensitive mutants in immunity will 
serve to clarify the question. 
We have isolated a 660-basepair fragment of the 
Co1 El plasmid that contains the entire putative 
immunity gene. Although this gene is already 
located on a plasmid, its expression is very low, We 
have cloned the fragment into a plasmid contain- 
ing the regulatable lambda PL promoter. We hope 
to purify large quantities of the immunity protein 
from this strain. 
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